Managing Comorbidities to Reduce Cardiovascular Risk
Impact du Bilan et de la Prise en Charge Des comorbidités en médecine Interne Sur le Risque Cardiovasculaire
This study is testing a new way to help patients with multiple health issues lower their risk of heart problems while they are in the hospital.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT06204549 on ClinicalTrials.gov |
What this trial studies
This study focuses on assessing and managing cardiovascular risk in patients with multiple comorbidities during planned internal medicine hospitalizations. It aims to provide comprehensive, personalized care to high-risk patients, whether they are in primary or secondary prevention. The approach includes thorough evaluations such as blood pressure measurements, cardiac ultrasounds, and various biological assessments to identify and manage comorbidities effectively. The goal is to evaluate the effectiveness of this multidisciplinary management strategy in reducing cardiovascular morbidity and mortality.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and over with high cardiovascular risk, either in primary prevention with multiple risk factors or in secondary prevention following a major cardiovascular event.
Not a fit: Patients who may not benefit include those who refuse participation, are not registered in the social security system, or are pregnant or breastfeeding.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of adverse cardiac events in high-risk patients.
How similar studies have performed: Other studies have shown success in managing comorbidities to improve cardiovascular outcomes, indicating that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * High-Risk Cardiovascular patients either receiving: * Primary prevention because they have never had a cardiovascular event but have several cardiovascular risk factors such as high blood pressure particularly resistant, metabolic syndrome, diabetes , dyslipidemia, metabolic steatosis * Or secondary prevention because they have already had a major cardiovascular event such as ischemic heart disease, heart failure * Aged 18 and over * Patient benefiting from comorbidities assessment during their planned hospitalization in the internal medicine department. Exclusion Criteria: * Patient refusal * Subject not registered in social security system * Pregnant or breastfeeding woman * Patient unable to give their informed consent, protected adult, vulnerable people * Subject deprived of liberty by judicial or administrative decision
Where this trial is running
Montpellier
- University Hospital — Montpellier, France (Recruiting)
Study contacts
- Principal investigator: Camille ROUBILLE, MD — University Hospital, Montpellier
- Study coordinator: Fanny CARDON
- Email: fanny-cardon@chu-montpellier.fr
- Phone: 0033 4 67 33 08 24
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.